Search Results - "Olesen, M. S."

Refine Results
  1. 1

    High prevalence of genetic variants previously associated with Brugada syndrome in new exome data by Risgaard, B, Jabbari, R, Refsgaard, L, Holst, AG, Haunsø, S, Sadjadieh, A, Winkel, BG, Olesen, MS, Tfelt-Hansen, J

    Published in Clinical genetics (01-11-2013)
    “…More than 300 variants in 12 genes have been associated with Brugada syndrome (BrS) which has a prevalence ranging between 1:2000 and 1:100,000. Until…”
    Get full text
    Journal Article
  2. 2

    Distinguishing pathogenic mutations from background genetic noise in cardiology: The use of large genome databases for genetic interpretation by Ghouse, J., Skov, M.W., Bigseth, R.S., Ahlberg, G., Kanters, J.K., Olesen, M.S.

    Published in Clinical genetics (01-03-2018)
    “…Advances in clinical genetic testing have led to increased insight into the human genome, including how challenging it is to interpret rare genetic variation…”
    Get full text
    Journal Article
  3. 3

    Integration of 60,000 exomes and ACMG guidelines question the role of Catecholaminergic Polymorphic Ventricular Tachycardia‐associated variants by Paludan‐Müller, C., Ahlberg, G., Ghouse, J., Herfelt, C., Svendsen, J.H., Haunsø, S., Kanters, J.K., Olesen, M.S.

    Published in Clinical genetics (01-01-2017)
    “…Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a highly lethal cardiac arrhythmia disease occurring during exercise or psychological stress…”
    Get full text
    Journal Article
  4. 4

    Risk prediction of cardiovascular death based on the QTc interval: evaluating age and gender differences in a large primary care population by Nielsen, Jonas B, Graff, Claus, Rasmussen, Peter V, Pietersen, Adrian, Lind, Bent, Olesen, Morten S, Struijk, Johannes J, Haunsø, Stig, Svendsen, Jesper H, Køber, Lars, Gerds, Thomas A, Holst, Anders G

    Published in European heart journal (21-05-2014)
    “…Using a large, contemporary primary care population we aimed to provide absolute long-term risks of cardiovascular death (CVD) based on the QTc interval and to…”
    Get full text
    Journal Article
  5. 5

    Incomplete right bundle branch block: a novel electrocardiographic marker for lone atrial fibrillation by Nielsen, Jonas Bille, Olesen, Morten Salling, Tangø, Mogens, Haunsø, Stig, Holst, Anders Gaarsdal, Svendsen, Jesper Hastrup

    Published in Europace (London, England) (01-02-2011)
    “…P-wave morphology and PR interval have both been previously associated with atrial fibrillation (AF). We hypothesized that incomplete right bundle branch block…”
    Get full text
    Journal Article
  6. 6

    Dissecting genetics in hypothyroidism as an independent risk factor in atherosclerotic disease by Rand, S, Haunsoe, S, Olesen, M S, Ghouse, J

    Published in European heart journal (03-10-2022)
    “…Abstract Background Thyroid disease comprises a joint group of diseases estimated to affect 10% of the general adult population [1]. Hypothyroidism is…”
    Get full text
    Journal Article
  7. 7

    Proteomic and genomic evaluation of plasma protein biomarkers for atrial fibrillation by Vad, O B, Paludan-Muller, C, Diederichsen, S Z, Svendsen, J H, Olesen, M S

    Published in European heart journal (28-10-2024)
    “…Abstract Background Atrial fibrillation (AF) is a common arrhythmia and an important cause of ischemic stroke. Several plasma proteins have been suggested as…”
    Get full text
    Journal Article
  8. 8

    Early-onset atrial fibrillation is a risk marker for cardiomyopathy: genetic insights from the UK Biobank by Bech, Q, Vad, O B, Paludan-Muller, C, Svendsen, J H, Olesen, M S

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of stroke, heart failure and premature death…”
    Get full text
    Journal Article
  9. 9

    Potential use of pharmacogenetics in cardiology: genome-wide association studies of amiodarone-induced thyroid disorders by Rand, S, Tragante, V, Sorensen, E, Ostrowski, S R, Pedersen, O B, Olesen, M S, Bundgaard, H, Ghouse, J

    Published in European heart journal (28-10-2024)
    “…Abstract Background Amiodarone is a commonly prescribed antiarrhythmic drug used to manage supraventricular and ventricular arrhythmias. The use of amiodarone…”
    Get full text
    Journal Article
  10. 10

    Genome-wide association study of amidoarone-induced hypothyroidism by Rand, S, Olesen, M S, Ostrowski, S R, Sorensen, E, Pedersen, O B, Bundgaard, H, Ghouse, J

    Published in European heart journal (09-11-2023)
    “…Abstract Background Amiodarone is a commonly prescribed antiarrhythmic drug used to manage supraventricular and ventricular arrhythmias. The use of amiodarone…”
    Get full text
    Journal Article
  11. 11

    Genome-wide association study of atrial fibrillation in 114,539 Finnish individuals reveals novel locus associated with cardiac remodelling by Paludan-Muller, C, Vad, O B, Svendsen, J H, Olesen, M S

    Published in European heart journal (12-10-2021)
    “…Abstract Background/Introduction Atrial fibrillation (AF) is the most common cardiac arrhythmia and it is associated with serious complications, such as…”
    Get full text
    Journal Article
  12. 12

    Circadian rhythm in atrial fibrillation detected by implantable loop recorder: a post-hoc analysis of a randomized clinical trial by Spona, D, Haugan, K J, Graff, C, Hoejberg, S, Krieger, D, Brandes, A, Koeber, L, Olesen, M S, Svendsen, J H, Diederichsen, S Z

    Published in European heart journal (28-10-2024)
    “…Abstract Introduction Previous studies suggest the existence of circadian, weekly, and seasonal rhythms in the occurrence of atrial fibrillation (AF), which…”
    Get full text
    Journal Article
  13. 13

    Genome-wide multi-trait analysis on cardioembolic stroke identifies 47 novel loci by Meseguer Monfort, L, Ahlberg, G, Andreasen, L, Ghouse, J, Haunso, S, Bundgaard, H, Svendsen, J H, Olesen, M S

    Published in European heart journal (03-10-2022)
    “…Abstract Background Ischemic stroke is one of the leading causes of death and disability-adjusted life-years worldwide. It has several subtypes and…”
    Get full text
    Journal Article
  14. 14

    The rs13376333 risk allele mimics the effect of atrial fibrillation on SK-current density and afterdepolarizations in human atrial myocytes by Jimenez-Sabado, V, Tarifa, C, Casabella-Ramon, S, Montiel, J, Rodriguez-Font, E, Olesen, M S, Hove-Madsen, L

    Published in European heart journal (03-10-2022)
    “…Abstract Background Various genome wide association studies have associated the single nucleotide polymorphism (SNP) rs13376333 with increased risk of atrial…”
    Get full text
    Journal Article
  15. 15

    Atrial fibrillation screening to prevent stroke in persons with low-normal thyrotropin by Diederichsen, S Z, Spona, D, Frodi, D M, Xing, L Y, Kongebro, E K, Haugan, K J, Graff, C, Hoejberg, S, Krieger, D, Brandes, A, Koeber, L, Olesen, M S, Andersen, A, Haedersdal, S, Frikke-Schmidt, R

    Published in European heart journal (28-10-2024)
    “…Abstract Background Screening for atrial fibrillation (AF) has been proposed as a method to prevent strokes in high-risk individuals. Recent trials were unable…”
    Get full text
    Journal Article
  16. 16

    Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease by Xing, L Y, Diederichsen, S Z, Hojberg, S, Krieger, D W, Graff, C, Olesen, M S, Brandes, A, Kober, L, Haugan, K J, Svendsen, J H

    Published in European heart journal (03-10-2022)
    “…Abstract Background Previous research has showed that various cardiovascular diseases (CVD) are associated with increased risks of atrial fibrillation (AF) and…”
    Get full text
    Journal Article
  17. 17

    Genome-wide association study on cerebral white-matter hyperintensities in 36,577 individuals by Jespersen, J, Ahlberg, G, Andreasen, L, Ghouse, J, Frederiksen, K S, Haunsoe, S, Svendsen, J H, Frikke-Schmidt, R, Olesen, M S, Bundgaard, H

    Published in European heart journal (03-10-2022)
    “…Abstract Background/Introduction A quarter of all strokes are caused by cerebral small vessel disease (CSVD), which is also the most common pathology…”
    Get full text
    Journal Article
  18. 18

    High prevalence of deleterious variants in cardiomyopathy genes in patients with early onset atrial fibrillation by Vad, O B, Ahlberg, G, Paludan-Muller, C, Refsgaard, L, Sajadieh, A, Haunsoe, S, Bundgaard, H, Svendsen, J H, Olesen, M S

    Published in European heart journal (03-10-2022)
    “…Abstract Background Atrial Fibrillation (AF) is a common cardiac arrhythmia associated with increased morbidity and mortality. AF has a significant heritable…”
    Get full text
    Journal Article
  19. 19

    P6269Early glycemic changes after initiation of oral anti-diabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes by Ghouse, J, Skov, M W, Olesen, M S, Holst, A G, Nielsen, J B

    Published in European heart journal (01-10-2019)
    “…Abstract Background Results from randomized trials in patients with type 2 diabetes have led to concerns regarding the safety and efficacy of aiming for…”
    Get full text
    Journal Article
  20. 20

    Loss-of-function variants in founder population highlight atrial myopathy as susceptibility to atrial fibrillation by Paludan-Muller, C, Vad, O B, Kahnert, K, Ahlberg, G, Monfort, L M, Rand, S A, Trudsoe, L C, Andreasen, L, Christensen, A H, Bundgaard, H, Lundby, A, Svendsen, J H, Olesen, M S

    Published in European heart journal (03-10-2022)
    “…Abstract Background Atrial fibrillation (AF) is the most common cardiac arrhythmia, and it's associated with genes responsible for cardiac conduction,…”
    Get full text
    Journal Article